Develops neural stem cells for treating Parkinson's disease.
Jun 2026Revenue $9.51M/yrExpenses $9.96M/yr
No trend
Figures by year
When will International Stem Cell be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $9.51M and expenses $9.96M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $9.10M | $9.37M | −$267K |
| Dec 2024 | $9.09M | $9.15M | −$68.0K |
| Dec 2023 | $7.79M | $8.45M | −$663K |
| Dec 2022 | $8.18M | $8.36M | −$183K |
| Dec 2021 | $7.18M | $9.10M | −$1.92M |
| Dec 2020 | $7.13M | $9.95M | −$2.82M |
| Dec 2019 | $9.47M | $15.2M | −$5.73M |
| Dec 2018 | $11.1M | $14.6M | −$3.47M |
| Dec 2017 | $7.46M | $12.4M | −$4.94M |
| Dec 2016 | $7.17M | $12.0M | −$4.85M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.